This study is looking at how a drug called MAR001 affects adults who have high levels of triglycerides (a type of fat in the blood). Researchers want to see if MAR001 can lower these triglyceride levels after a meal, compared to a placebo (an inactive substance). You might be able to join if you are between 18 and 75 years old, have elevated triglycerides, and your HbA1c (a measure of blood sugar) is between 5.7% and 8.5%. The study will measure changes in your triglyceride levels 12 weeks after starting the treatment to see if MAR001 is successful. The current status of this study is unclear, and it plans to enroll 30 participants.

Study design

This is an interventional study comparing MAR001 to a placebo. It plans to enroll 30 participants.

What's involved

You would need to provide informed consent and follow all study assessments. You would also need two fasting triglyceride measurements at separate visits during screening, and a stable diet for at least 3 months prior to screening and throughout the study.

Compensation

Not stated in the trial record.

Follow-up

The primary measurements for the study are taken at 12 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.